Skip to main content
Premium Trial:

Request an Annual Quote

HGS Appoints Russell as Pharmacology Director

Premium

ROCKVILLE, Md.--Human Genome Sciences announced that Deborah Austin Russell joined the company as director of pharmacology earlier this month. Russell moved from Amgen, in Thousand Oaks, Calif., where she concentrated on the biological effects of novel proteins in model systems. Russell had spent five years at Synergen in Boulder, Colo., before it was acquired by Amgen. William Haseltine, HGS chairman, said Russell's strategic challenge is to link market opportunities to relevant models of disease to enhance the company's ability to move appropriate novel therapeutic protein product candidates through the development process.

Filed under

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.